Literature DB >> 11348458

Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid.

M Westergaard1, J Henningsen, M L Svendsen, C Johansen, U B Jensen, H D Schrøder, I Kratchmarova, R K Berge, L Iversen, L Bolund, K Kragballe, K Kristiansen.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are pleiotropic regulators of growth and differentiation of many cell types. We have performed a comprehensive analysis of the expression of PPARs, transcriptional cofactors, and marker genes during differentiation of normal human keratinocytes using a combination of reverse transcriptase polymerase chain reaction, Northern and Western blotting, and immunohistochemistry. PPARdelta was the predominant PPAR subtype in human keratinocytes and highly expressed in basal cells and suprabasal cells. Induction of PPARalpha and PPARgamma expression was linked to differentiation, and accordingly, expression of PPARalpha and PPARgamma was in essence confined to suprabasal cells. Differentiation was not accompanied by significant changes in the expression of the coactivators CREB-binding protein, p300, steroid receptor coactivator 1, or the corepressors nuclear receptor corepressor and silence mediator for retinoid and thyroid hormone receptors. We critically evaluated the effects of selective PPAR ligands and a synthetic fatty acid analog, tetradecylthioacetic acid. Tetradecylthioacetic acid activated all human PPAR subtypes in the ranking order PPARdelta >> PPARalpha > PPARgamma. All selective PPAR ligands marginally induced transglutaminase-1 expression with the PPARdelta-selective ligand L165041 being the most potent. The PPARalpha- and PPARgamma-selective ligands Wy14643 and BRL49653 had negligible effect on involucrin expression, whereas a dose-dependent induction was observed with L165041. Simultaneous addition of L165041 and BRL49653 synergistically induced strong involucrin expression. Additionally, L165041 potently induced CD36 mRNA expression. Administration of tetradecylthioacetic acid resulted in a dramatic decrease in proliferation and a robust upregulation of the expression of involucrin and transglutaminase. Our results indicate that tetradecylthioacetic acid may affect keratinocyte gene expression and differentiation via PPAR-dependent and PPAR-independent pathways, and that the latter play an important role.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348458     DOI: 10.1046/j.1523-1747.2001.01329.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  59 in total

1.  PPAR-alpha in cutaneous inflammation.

Authors:  Sandrine Dubrac; Matthias Schmuth
Journal:  Dermatoendocrinol       Date:  2011-01

2.  Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.

Authors:  Anne-M Krogsdam; Curt A F Nielsen; Søren Neve; Dorte Holst; Torben Helledie; Bo Thomsen; Christian Bendixen; Susanne Mandrup; Karsten Kristiansen
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

3.  Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Authors:  Bokai Zhu; Combiz Khozoie; Moses T Bility; Christina H Ferry; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

Review 4.  Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis.

Authors:  Nicolas Di-Poï; Liliane Michalik; Béatrice Desvergne; Walter Wahli
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

Review 5.  Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.

Authors:  Jeffrey M Peters; Jennifer E Foreman; Frank J Gonzalez
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

6.  Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells.

Authors:  Michael G Borland; Ellen M Kehres; Christina Lee; Ashley L Wagner; Brooke E Shannon; Prajakta P Albrecht; Bokai Zhu; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2018-05-03       Impact factor: 4.221

7.  The peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes.

Authors:  Raymond L Konger; Kellie Clay Martel; Danielle Jernigan; Qiwei Zhang; Jeffrey B Travers
Journal:  PPAR Res       Date:  2010-05-19       Impact factor: 4.964

8.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

Authors:  Weiwei Shan; Prajakta S Palkar; Iain A Murray; Emily I McDevitt; Mary J Kennett; Boo Hyon Kang; Harriet C Isom; Gary H Perdew; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2008-07-12       Impact factor: 4.849

9.  Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification.

Authors:  Joachim W Fluhr; Mao-Qiang Man; Jean-Pierre Hachem; Debra Crumrine; Theodora M Mauro; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

10.  Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2.

Authors:  Katarina Mariann Jørgensen; Hanne Solvang Felberg; Rolf K Berge; Astrid Laegreid; Berit Johansen
Journal:  Arch Dermatol Res       Date:  2009-12-30       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.